Neogen Chemicals has officially disclosed that its fundraising committee has authorized a Qualified Institutions Placement equity stock raise. The capital raising scheme will raise an aggregate amount of ₹600 crore. The issuance was made after obtaining the required approvals through a board resolution dated 24 July 2026 and a subsequent special resolution approved by the shareholders of the company in the Extraordinary General Meeting held on 21 August 2026.

The transaction is a significant corporate move by the chemical manufacturer to build a stronger financial balance sheet and fund future operations.

Floor price details and final issue size

The issue was fixed by the fundraising committee for Neogen Chemicals on 10 September 2026. According to the guiding principles of the Securities and Exchange Board of India, the committee had set a floor price of ₹2,189.73 per equity share for the offering. 

This is a firm price attributed to the bottom band of the range and is 8.25% lower than the last closing price of ₹2,386.55 on the BSE. According to regulation, the company can supply a discount of up to 5% off the rate listed on the floor. 

The issue comprises equity shares with a face value of ₹10. The actual number of shares issued in the equity and the final equity share price shall be decided by the company in consultation with the appointed book running lead manager or managers.

Fund utilization and financial performance

The management of Neogen Chemicals has indicated a clear direction for the allocation of capital collected from this issue. The proceeds of the issue, net of repayments or pre-payments, shall be used by the company for the repayment or pre-payment in full or in part of certain borrowings availed by the company. 

In addition to meeting its corporate loan commitment, the proceeds will be used to meet long-term working capital needs of the company. Furthermore, the raised funds will be used for general corporate expenses for the purpose of advancing the business and to promote the flexibility of operations.

Neogen Chemicals is one of the prominent players in the specialty chemical sector in India, with a turnover of tremendous magnitude. The business product assortment contains a broad selection of organic and inorganic chemicals to meet varied industrial markets. On the financial side, the company’s most recent quarterly data for Q1 FY27 shows an increase in consolidated net profit by 66.76% to ₹17.11 crore. 

The increase in profitability was witnessed alongside a 34.04% increase in total revenues that amounted to ₹250.29 crore for Q1 FY27 compared to the corresponding quarter in Q1 FY27. Notwithstanding the core performance, the stock underwent market activity with a fall of 2.88% and traded at ₹2317.90 on the BSE recently.

Conclusion

The Qualified Institutions Placement issue of ₹600 crore is an important factor for Neogen Chemicals in making its capital structure more operationally efficient. With the establishment of the minimum floor price of ₹2,189.73 per equity share, the firm creates room for institutional involvement based on the guidelines set out by SEBI. Allocation of the net proceeds for debt repayment, working capital purposes, and general corporate purposes aims to strengthen the financial position.

Neogen Chemicals is looking to use the funds raised to strengthen its market position, following the strong growth in consolidated net profit in its Q1 FY27 results and its expanding revenue base within specialty chemicals across Bromine-based and Lithium-based segments.